John Hural

6.1k total citations · 1 hit paper
35 papers, 1.6k citations indexed

About

John Hural is a scholar working on Virology, Immunology and Molecular Biology. According to data from OpenAlex, John Hural has authored 35 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Virology, 13 papers in Immunology and 12 papers in Molecular Biology. Recurrent topics in John Hural's work include HIV Research and Treatment (20 papers), vaccines and immunoinformatics approaches (9 papers) and Immunotherapy and Immune Responses (7 papers). John Hural is often cited by papers focused on HIV Research and Treatment (20 papers), vaccines and immunoinformatics approaches (9 papers) and Immunotherapy and Immune Responses (7 papers). John Hural collaborates with scholars based in United States, South Africa and United Kingdom. John Hural's co-authors include Melissa A. Brown, Matthew A. Brown, M. Juliana McElrath, Steven G. Self, Zoe Moodie, Olivier Defawe, Lawrence Corey, Susan Buchbinder, Stephen C. De Rosa and Holly Janes and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

John Hural

34 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis

2008 517 citations M. Juliana McElrath, Stephen C. De Rosa et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Hural United States	18	804	619	544	414	360	35	1.6k
Andrew N. Harman Australia	26	1.3k 1.6×	846 1.4×	500 0.9×	545 1.3×	334 0.9×	52	2.1k
Shawn P. O’Neil United States	23	1.2k 1.4×	1.3k 2.0×	324 0.6×	529 1.3×	455 1.3×	42	2.1k
Anne‐Sophie Beignon France	23	1.5k 1.9×	618 1.0×	428 0.8×	377 0.9×	324 0.9×	43	2.1k
Edward Seung United States	20	1.3k 1.6×	424 0.7×	452 0.8×	286 0.7×	275 0.8×	27	2.2k
George Makedonas United States	25	1.3k 1.6×	619 1.0×	319 0.6×	468 1.1×	361 1.0×	44	2.0k
T A Wiltrout United States	17	737 0.9×	710 1.1×	338 0.6×	289 0.7×	434 1.2×	20	1.5k
Christian Körner Germany	29	1.1k 1.3×	206 0.3×	700 1.3×	524 1.3×	159 0.4×	52	2.2k
John P. Donahue United States	23	426 0.5×	302 0.5×	806 1.5×	199 0.5×	413 1.1×	50	1.9k
Jesper Melchjorsen Denmark	26	1.4k 1.7×	468 0.8×	564 1.0×	818 2.0×	521 1.4×	35	2.3k
Beda Břicháček United States	25	864 1.1×	1.5k 2.4×	675 1.2×	653 1.6×	882 2.5×	68	2.6k

Countries citing papers authored by John Hural

Since Specialization

Citations

This map shows the geographic impact of John Hural's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Hural with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Hural more than expected).

Fields of papers citing papers by John Hural

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Hural. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Hural. The network helps show where John Hural may publish in the future.

Co-authorship network of co-authors of John Hural

This figure shows the co-authorship network connecting the top 25 collaborators of John Hural. A scholar is included among the top collaborators of John Hural based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Hural. John Hural is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hural, John, Ole Lagatie, Ludo Lavreys, et al.. (2024). HIV Diagnostics and Vaccines: It Takes Two to Tango. The Journal of Infectious Diseases. 229(6). 1919–1925. 3 indexed citations

Espy, Nicole, Xue Han, Shannon Grant, et al.. (2023). Cross-protocol assessment of induction and durability of VISP/R in HIV preventive vaccine trial participants. SHILAP Revista de lepidopterología. 3(6). e0002037–e0002037. 2 indexed citations

Huang, Yunda, Oleg Borisov, Jia Jin Kee, et al.. (2021). Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation. Scientific Reports. 11(1). 23921–23921. 20 indexed citations

Keech, Cheryl, Porter Anderson, Jorge Flores, et al.. (2020). A Phase 1 Randomized, Placebo-controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of Inactivated Streptococcus pneumoniae Whole-cell Vaccine in Adults. The Pediatric Infectious Disease Journal. 39(4). 345–351. 19 indexed citations

Seaton, Kelly E., Michael S. Piepenbrink, John Hural, et al.. (2020). Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature. Scientific Reports. 10(1). 13031–13031. 6 indexed citations

Brown, Matthew A. & John Hural. (2017). Functions of IL-4 and Control of Its Expression. Critical Reviews in Immunology. 37(2-6). 181–212. 85 indexed citations

Jacobson, Jeffrey M., Lu Zheng, Cara C. Wilson, et al.. (2015). The Safety and Immunogenicity of an Interleukin-12–Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 71(2). 163–171. 21 indexed citations

Bart, Pierre‐Alexandre, Yunda Huang, Shelly Karuna, et al.. (2014). HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial. Journal of Clinical Investigation. 124(11). 4843–4856. 18 indexed citations

Krueger, N., Isaac R. Rodriguez‐Chavez, Michael P. Busch, et al.. (2014). Performance of a Redesigned HIV Selectest Enzyme-Linked Immunosorbent Assay Optimized To Minimize Vaccine-Induced Seropositivity in HIV Vaccine Trial Participants. Clinical and Vaccine Immunology. 21(3). 391–398. 13 indexed citations

10.

Stephenson, Kathryn E., John Hural, Susan Buchbinder, Faruk Sinangil, & Dan H. Barouch. (2012). Preexisting Adenovirus Seropositivity Is Not Associated With Increased HIV-1 Acquisition in Three HIV-1 Vaccine Efficacy Trials. The Journal of Infectious Diseases. 205(12). 1806–1810. 14 indexed citations

11.

Kalams, Spyros A., Scott Parker, Xia Jin, et al.. (2012). Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine with or without IL-12 and/or IL-15 Plasmid Cytokine Adjuvant in Healthy, HIV-1 Uninfected Adults. PLoS ONE. 7(1). e29231–e29231. 90 indexed citations

12.

Cheng, Cheng, Jason G. Gall, Martha Nason, et al.. (2012). Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination. PLoS ONE. 7(4). e33969–e33969. 19 indexed citations

13.

Goepfert, Paul A., Marnie Elizaga, Alicia Sato, et al.. (2011). Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles. The Journal of Infectious Diseases. 203(5). 610–619. 120 indexed citations

14.

Weinberg, Adriana, Lin Song, Terry Fenton, et al.. (2010). Optimization of storage and shipment of cryopreserved peripheral blood mononuclear cells from HIV-infected and uninfected individuals for ELISPOT assays. Journal of Immunological Methods. 363(1). 42–50. 50 indexed citations

15.

McElrath, M. Juliana, Stephen C. De Rosa, Zoe Moodie, et al.. (2008). HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis. The Lancet. 372(9653). 1894–1905. 517 indexed citations breakdown →

16.

Moodie, Zoe, Yunda Huang, Lin Gu, John Hural, & Steven G. Self. (2006). Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials. Journal of Immunological Methods. 315(1-2). 121–132. 50 indexed citations

17.

Hural, John, et al.. (2002). Identification of Naturally Processed CD4 T Cell Epitopes from the Prostate-Specific Antigen Kallikrein 4 Using Peptide-Based In Vitro Stimulation. The Journal of Immunology. 169(1). 557–565. 32 indexed citations

18.

Hural, John, et al.. (2000). An Intron Transcriptional Enhancer Element Regulates IL-4 Gene Locus Accessibility in Mast Cells. The Journal of Immunology. 165(6). 3239–3249. 57 indexed citations

19.

Brown, Melissa A. & John Hural. (1997). Functions of IL-4 and Control of Its Expression. Critical Reviews in Immunology. 17(1). 1–32. 256 indexed citations

20.

Webber, Stephanie, John Hural, & John M. Whiteley. (1988). The estimation of dihydropteridine reductase in human blood cells. Clinica Chimica Acta. 173(2). 117–126. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact